Catalyst Wire Dossier Catalyst Wire Dossier

Enurev Breezhaler

glycopyrronium bromide · Novartis Europharm Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Enurev Breezhaler, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: EMA Authorised: Enurev Breezhaler (glycopyrronium bromide) — Novartis Europharm Ltd

See pricing